All analyses
AI analysis

Softlogic Life Insurance PLC: research report

UndervaluedbullishAug 6, 2026

Softlogic Life has completed its Bangladesh entry, adding a new growth leg, while the share trades at 5.3x earnings and yields 12.1%.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Net margin
5.5%sector 4.1%
latest quarter
Return on equity
34.2%sector 7.2%
full year to Dec 31, 2025
P/E
5.2sector 13.1
earnings Rs 14.79 per share
P/B
1.66sector 1.52
book Rs 46.11 per share
Dividend yield
6.93%sector 1.78%
35.8% of earnings paid out

Current figures, updated daily from filings to Jun 30, 2026. The report below was written on Aug 6, 2026. Sector figures are the median of 11 listed companies in the same sector.

Overview

Softlogic Life Insurance is a Sri Lankan life insurer focused on protection and savings solutions, investing policyholder funds and distributing through field sales, bancassurance, digital and postal channels. The company has added a regional growth option by completing its first cross-border move with a controlling-stake acquisition in Bangladesh, alongside the earlier integration of Allianz Life Lanka that expanded its local sales force. At a market capitalisation of LKR 25.63 billion, the story now pivots from pure domestic scale-up to execution on multi-market growth and disciplined capital deployment. For a life insurer, consistent underwriting discipline, claims management and investment returns drive value; the recent strategic step-up raises the stakes on all three, but also broadens the runway beyond Sri Lanka’s economic cycle.

Price performance

Momentum has cooled near term, with the share down 13.3% over three months and 9.0% over one month. Liquidity is adequate for the CSE, with average daily volume around 182,230 shares. The 52-week range of LKR 70.00 to LKR 97.90 shows investors have faded the mid-year highs, and the current beta to the ASPI at 1.05 indicates index-like co-movement rather than idiosyncratic swings. The one-year picture is steadier than recent weeks, but the retracement leaves room for a re-rating if earnings delivery and the Bangladesh build-out sustain sentiment. For now, the tape is cautious but not broken.

Valuation

The stock trades at 5.26x earnings versus a sector median of 14.75x, a wide discount for a franchise posting strong profitability. Price-to-book is 1.83x against a sector median 1.09x, which is explained by a high 34.2% ROE that justifies a premium to book. The dividend yield at 12.1% signals compelling cash returns while leaving modest reinvestment capacity from retained earnings. Taken together, a low P/E, premium P/B and high ROE are a coherent mix for an insurer monetising equity efficiently; if execution on growth and capital management holds, the multiple gap to peers has room to narrow.

News and sentiment

Coverage has been active and constructive: 11 material articles over 90 days, with 9 positive, 1 negative and 1 neutral. The key catalyst was the completion of a 60% acquisition of Bangladesh’s Diamond Life Insurance for about $1.9 million, opening a new market. A cash dividend was also confirmed, with an ex-date on 2026-07-02, supporting income credentials. An investor forum highlighted product innovation and digital investment, while a disclosed disposal by a large shareholder introduced some overhang risk but not a change in fundamentals. Overall tone has been expansionary and supportive of the long-term equity story.

Financials

The latest reported quarter to 31 Mar 2026 shows revenue of LKR 13.24 billion, with gross and operating margins at 7.4% and a net margin of 5.0%. Below the line items created a LKR 308 million drag, underscoring the importance of finance costs, tax and FX to reported earnings. A clean year-on-year margin comparison is not available because the prior-year quarter in the dataset is on a different reporting basis and key yoy fields are null. For context, full-year 2025 revenue grew 16.8%, indicating continued scale. Share count appears unchanged across the periods shown, so per-share trends reflect business performance rather than dilution.

Risks

Cross-border execution in Bangladesh raises regulatory, consumer and distribution risks in an unfamiliar market; early missteps could consume management bandwidth. Insurance earnings are sensitive to interest-rate paths and rupee moves, which influence reinvestment yields, asset valuations and the translation of foreign reinsurance costs. Health inflation and claims severity can pressure technical margins if pricing lags. Capital adequacy and dividend policy must balance growth, shocks and shareholder payouts. Finally, disclosed stake sales by a large shareholder can create technical overhang, amplifying price moves around news flow. None of these are unusual for insurers, but they elevate the importance of disciplined underwriting and ALM.

Outlook

Focus now shifts to two proof points: sustaining domestic premium momentum while integrating Bangladesh, and holding profitability in a normalising rate environment. Confirmation would be a quarterly net margin at or above 5% alongside stable crediting and reinsurance costs. Watch for early operating updates from the Bangladesh subsidiary, particularly distribution build and product approvals, as signals of execution speed. With rates and the rupee broadly steady, investment income should be supportive, but any shock to yields or FX could test mark-to-market resilience. Dividend sustainability will hinge on maintaining operating cash generation while funding growth; clear guidance on capital buffers would reduce uncertainty.

About this report. Generated on Aug 6, 2026 from market data up to Aug 5, 2026, 11 material news articles over 90 days and financials to Mar 31, 2026. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports